×

Jim Cramer talks influences that helped EpiPen price changes

10:48 AM ET Mon, 29 Aug 2016

CNBC's Jim Cramer says Monday recent price adjustments from EpiPen's owner Mylan can be partially attributed to the rise of vocal social media platforms.